Union Bancaire Privee UBP SA Boosts Stake in Xylem Inc. $XYL

Union Bancaire Privee UBP SA lifted its position in Xylem Inc. (NYSE:XYL) by 22.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 35,202 shares of the industrial products company’s stock after purchasing an additional 6,370 shares during the quarter. Union Bancaire Privee UBP SA’s holdings in Xylem were worth $4,677,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in XYL. SJS Investment Consulting Inc. lifted its stake in Xylem by 1,844.4% in the third quarter. SJS Investment Consulting Inc. now owns 175 shares of the industrial products company’s stock valued at $26,000 after buying an additional 166 shares during the last quarter. Knuff & Co LLC acquired a new position in shares of Xylem in the 3rd quarter valued at $27,000. Wexford Capital LP purchased a new stake in Xylem in the 3rd quarter valued at $27,000. First Horizon Corp purchased a new stake in Xylem in the 3rd quarter valued at $30,000. Finally, Ramirez Asset Management Inc. boosted its stake in Xylem by 100.0% during the 3rd quarter. Ramirez Asset Management Inc. now owns 200 shares of the industrial products company’s stock worth $30,000 after purchasing an additional 100 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Trading Down 0.2%

NYSE XYL opened at $120.30 on Friday. The company has a quick ratio of 1.28, a current ratio of 1.62 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $29.25 billion, a P/E ratio of 30.69, a P/E/G ratio of 1.72 and a beta of 1.17. Xylem Inc. has a 52-week low of $100.47 and a 52-week high of $154.27. The firm has a 50-day moving average price of $132.03 and a 200 day moving average price of $139.12.

Xylem (NYSE:XYL) last announced its quarterly earnings data on Tuesday, February 10th. The industrial products company reported $1.42 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.42. Xylem had a return on equity of 11.11% and a net margin of 10.59%.During the same period last year, the firm posted $1.18 EPS. Xylem’s quarterly revenue was up 6.3% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.560 EPS. Equities research analysts expect that Xylem Inc. will post 4.65 EPS for the current year.

Xylem announced that its board has approved a share repurchase plan on Wednesday, February 25th that allows the company to repurchase $1.50 billion in shares. This repurchase authorization allows the industrial products company to buy up to 4.8% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company’s board believes its shares are undervalued.

Xylem Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 24th. Investors of record on Tuesday, February 24th will be paid a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.4%. This is a boost from Xylem’s previous quarterly dividend of $0.40. The ex-dividend date is Tuesday, February 24th. Xylem’s dividend payout ratio (DPR) is presently 43.88%.

Wall Street Analysts Forecast Growth

A number of research firms have commented on XYL. William Blair began coverage on shares of Xylem in a report on Monday, January 26th. They issued an “outperform” rating for the company. Barclays dropped their price target on Xylem from $166.00 to $156.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 11th. Citigroup reduced their price objective on Xylem from $182.00 to $174.00 and set a “buy” rating for the company in a research note on Wednesday, February 11th. Wall Street Zen downgraded Xylem from a “buy” rating to a “hold” rating in a research note on Saturday, December 27th. Finally, Oppenheimer set a $165.00 target price on Xylem in a report on Thursday, February 12th. Nine investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $158.08.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.